Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
AKTS
AMPH
Add up to 3 more stocks
AKTS
Aktis Oncology, Inc.
-1.13%
$18.31-0.21Delayed quote: Oct 6, 2026, 12:50 PM EDT
Market Cap
$977.84M
52W Range
$14.72 - $34.19
AMPH
Amphastar Pharmaceuticals, Inc.
+0.91%
$25.60+0.23Delayed quote: Oct 6, 2026, 12:50 PM EDT
Market Cap
$1.13B
52W Range
$16.65 - $29.52
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | 15.15 |
| Forward P/E | N/A | 8.62 |
| PEG Ratio | N/A | 0.11 |
| P/B Ratio | 2.02 | 1.47 |
| P/S Ratio | 97.20 | 1.55 |
| P/FCF Ratio | N/A | 7.38 |
| EV/EBITDA | N/A | 8.88 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 100.0% | 47.7% |
| Operating Margin | -1149.5% | 15.7% |
| Net Margin | -727.0% | 10.8% |
| ROE | -15.1% | 10.2% |
| ROA | -13.1% | 4.5% |
| ROIC | -16.5% | 5.9% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 16.33 | 2.40 |
| Quick Ratio | 16.33 | 1.71 |
| Debt/Equity | 0.02 | 0.90 |
| Interest Coverage | N/A | 5.51 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.